Q301--36C25926Q0220 | Prostate Cancer Testing Artificial Intelligence (AI)

SOL #: 36C25926Q0220Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NETWORK CONTRACT OFFICE 19 (36C259)
Greenwood Village, CO, 80111, United States

Place of Performance

Aurora, Colorado

NAICS

Medical Laboratories (621511)

PSC

Reference Laboratory Testing (Q301)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Timeline

1
Posted
Jun 11, 2026
2
Submission Deadline
Jul 13, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Rocky Mountain Regional VA Medical Center (RMRVAMC), is soliciting quotes for Artificial Intelligence (AI) Prostate Cancer Testing services. This Request for Quote (RFQ) aims to establish a new Five-Year Blanket Purchase Agreement (BPA) for a firm-fixed price contract. This opportunity is a Total Small Business Set-Aside. Quotes are due by 08:00 AM MT on July 13, 2026.

Purpose & Scope

The primary objective is to provide AI-based prognostic and predictive prostate cancer diagnostic testing using biopsy slides to enhance clinical decision-making for Veterans. This includes assessing metastatic risk, identifying patients who may benefit from combined radiation therapy and Androgen Deprivation Therapy (ADT), and determining suitability for Active Surveillance. The contractor will provide all necessary equipment, reagents, laboratory testing, analysis, result interpretation, shipping, and consultative services. Services must comply with Medicare and Medicaid regulations, federal and state laws, CLIA/CLSI standards, and HIPAA. Testing must support NCCN-consistent risk stratification and provide a 10-year risk assessment for distant metastasis and mortality.

Contract Details

  • Opportunity Type: Request for Quote (RFQ) for a Combined Synopsis/Solicitation (FAR Part 12).
  • Contract Vehicle: New Five-Year Blanket Purchase Agreement (BPA).
  • Contract Type: Firm-Fixed Price.
  • NAICS Code: 621511 Medical Laboratories, with a $41.5 Million size standard.
  • Set-Aside: Total Small Business Set-Aside (FAR 19.5).
  • Place of Performance: Rocky Mountain Regional VA Medical Center (RMRVAMC), Aurora, CO.
  • Period of Performance: The base period for line item 0001 is from August 1, 2026, to July 31, 2031, with an option to extend services up to 6 months.
  • Award Basis: All or Nothing.

Submission & Evaluation

  • Questions Due: June 22, 2026, 08:00 AM MT.
  • Quotes Due: July 13, 2026, 08:00 AM MT.
  • Submission Method: Email quotes to Alejandra.Sierra@va.gov and NCO19Lab@va.gov (4MB email limit). Faxed or hand-carried quotes will not be accepted.
  • Required Volumes: Quotes must include Volume I (Technical Capability), Volume II (Past Performance), and Volume III (Price).
    • Technical Capability: Demonstrate how requirements of the Statement of Work (SOW) are met, including brochures, data sheets, and technical specifications. Offerors must specify agreement or exceptions to SOW terms.
    • Past Performance: Provide up to two recent (within 3 years) and relevant past performance references, including completed Past Performance Questionnaires (PPQ) (Attachment S02).
    • Price: Complete the attached Line-Item Schedule.
  • Evaluation: Award will be made on a best-value basis using a Comparative Analysis, considering Technical Capability/Quality, Past Performance, and Price. Technical capability is paramount; quotes not meeting technical requirements will not be selected regardless of price.

Special Considerations

  • Offerors must be approved to provide clinical diagnostic laboratory tests under Medicare and Medicaid.
  • Compliance with FAR 52.222-90, "Addressing DEI Discrimination by Federal Contractors," is required.
  • SAM registration is mandatory.

People

Points of Contact

Alejandra SierraContracting SpecialistPRIMARY

Files

Files

Download
Download
Download
View
Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jun 11, 2026
Q301--36C25926Q0220 | Prostate Cancer Testing Artificial Intelligence (AI) | GovScope